Navigation Links
Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
Date:1/8/2010

FRAZER, Pa., Jan. 8 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) today announced that effective February 5, 2010, Robert P. Roche, Jr., Executive Vice President of Worldwide Pharmaceutical Operations, will resign his position with the company to pursue other longstanding interests. During his tenure, Mr. Roche established and grew the Cephalon sales and marketing organization into a global business that exceeded $2 billion in annual sales revenue. The company will announce plans for its leadership and the commercial organization in the near future. Additionally, the global commercial leadership team, Alain Aragues, President of Cephalon Europe, Paul Li, Senior Vice President of International Pharmaceutical Operations, and Robert Repella, Senior Vice President of U.S. Pharmaceutical Operations, will continue to lead their respective organizations.

"Bob Roche made a tremendous contribution to the worldwide commercial success of Cephalon. On behalf of the board of directors and executive team, I want to express my appreciation for his 15 years of excellent service and leadership in establishing Cephalon as one of the leading biopharmaceutical companies in the world," said Frank Baldino, Jr., Ph.D., Chairman and CEO. "Bob built strong global sales and marketing organizations and we remain enthusiastic about our growth opportunities and the future of our company."

Since 1995, Mr. Roche has led the worldwide commercial organization which now has more than 30 products. He was promoted to Senior Vice President, Worldwide Pharmaceutical Operations, in 2000, and named an Executive Vice President in 2005. Before joining Cephalon, Mr. Roche served as Director and Vice President, Worldwide Strategic Product Development, for SmithKline Beecham's central nervous system and gastrointestinal products busine
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
2. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
3. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
4. Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
5. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
6. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
7. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
10. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
11. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Calif. , Feb. 26, 2015  BD Life ... Company) (NYSE: BDX ), a leading ... innovative company focused on enabling high-resolution biology, today ... unique solutions for highly multiplexed cell isolation and ... are promoting BD,s powerful BD FACS™ single-cell sorting ...
(Date:2/26/2015)... Feb. 26, 2015  Spring Bank Pharmaceuticals, Inc., ... the treatment of virus infections, today announced that ... appointed Vice President of Finance, a newly created ... and administrative activities, including financial planning and reporting, ... Douglas J. Jensen , President and CEO. ...
(Date:2/26/2015)... , Feb. 26, 2015 Integrity Applications, Inc. ... GlucoTrack ® model DF-F, a noninvasive  device that tracks ... Heinemann , Ph.D., will head its new scientific advisory ... in the field of Diabetes research, monitoring and treatment. ... has been Chief Executive Officer and Head, Business Development ...
Breaking Medicine Technology:BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4
... Reportlinker.com announces that a new market research report ... Hospital Angiography Census http://www.reportlinker.com/p0362433/Hospital-Angiography-Census.html ... European market report on the installed base of ... CT, MRI,) and radiology IT systems (PACS, Teleradiology, ...
... someone needs high-quality drugs for less money, they are sure ... the large choice of pharmacies, it may not be easy ... things simpler and safer for anyone looking to buy ... promotion is the responsibility of the renowned search engine ...
Cached Medicine Technology:Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3New Online Pharmacy Rx-webmasters.com Allows Customers to Pay Less for High-Quality Drugs 2
(Date:2/27/2015)... Lyophilization has important applications in the pharmaceutical ... process to stabilize, store and increase the shelf life ... vaccines, antibodies, proteins, enzymes, hormones, blood plasma and ... freeze drying market was valued at $1,969.7 million in ... by 2019 at a CAGR of 6.2% during the ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 BaliniSports is ... with the online fitness social platform FITMOO. The collaboration ... products and holistic philosophy behind BaliniSports. Users of FITMOO ... an intimate way and discover apparel that will enhance ... that uses environmentally friendly and socially conscious methods to ...
(Date:2/27/2015)... Ticket Down announces that Ed Sheeran ... of 2015. Tickets for his tour have been a ... record pace. , Ed Sheeran 2015 Tour Dates: ... Wednesday, May 6, 2015 , 5/7/15, Ed Sheeran Tickets, Grand ... 2015 , 5/9/15, Ed Sheeran Tickets, Tulsa, OK BOK Center, ...
(Date:2/27/2015)... February 27, 2015 The decision to relocate ... newer facilities and to make camp more accessible to campers ... for a Contact Football Camp. The fields are in premier ... the country,” states Mike de Surville, vice president of US ... comprised of experienced coaches with the passion to create a ...
(Date:2/27/2015)... 2015 The report “Polycystic Ovarian ... information on the therapeutic development for polycystic ovarian ... which a woman's hormones are out of balance. ... teenage girls and young women. The cause of ... R&D pipelines by identifying new targets and MOAs ...
Breaking Medicine News(10 mins):Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:BaliniSports Announces Collaboration with FITMOO 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 3Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 4Health News:US Sports Camps Football Camps Announce New Contact Football Camp Northeast Location 2Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 2Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 3Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 4
... of information on multiple sclerosis medications and the financial help ... ... 2009 -- NeedyMeds, a national nonprofit, added a new resource page to ... page is a multiple sclerosis-specific source of help for those looking for ...
... OH, May 21, 2009 -- Type 1 diabetes is ... of this serious medical condition includes regular fingerstick glucose ... dose adjustments. Because children spend a great deal ... medical decisions and diabetes care. Some researchers believe ...
... 20 The following is a Statement of ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO )The Campaign ... (D-OH) for his leadership role in Senate committee ... and Drug Administration (FDA) regulatory authority over tobacco ...
... For the second time in two weeks, the ... a closed door committee session barring the public, media ... circumstances, like national security issues and trade secrets. Consumer ... questions about how its plan to require all Americans ...
... On May 20, 2009, the US District Court for ... (NYSE: AZN ) for an injunction barring Apotex ... of AstraZeneca,s PULMICORT RESPULES (budesonide inhalation suspension) in the US. ... set.On March 30, 2009, the US Food and Drug Administration ...
... The American Association for Homecare supports expanded anti-fraud efforts ... and the Department of Health and Human Services (HHS) ... two agencies outlined plans for expanding anti-fraud strike forces ... Care Fraud Prevention and Enforcement Action Team. Even ...
Cached Medicine News:Health News:New Source of Information on Multiple Sclerosis Medications 2Health News:Telemedicine may improve care for school children with diabetes 2Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 2Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 3Health News:Rarely Used Closed Doors Slammed Again in U.S. Senate Health Care Reform; Sen. Max Baucus Must Publicly Answer 10 Questions About Mandatory Purchase of Health Insurance 2Health News:Rarely Used Closed Doors Slammed Again in U.S. Senate Health Care Reform; Sen. Max Baucus Must Publicly Answer 10 Questions About Mandatory Purchase of Health Insurance 3Health News:Rarely Used Closed Doors Slammed Again in U.S. Senate Health Care Reform; Sen. Max Baucus Must Publicly Answer 10 Questions About Mandatory Purchase of Health Insurance 4Health News:Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation 2Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 2Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 3Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 4
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
... two groups of flexible lighting products. The ... in three different sizes 5", 10", and ... of the light). These lights are for ... needed., ,The second group of flexible ...
Medicine Products: